Form 4 for KROS Keros Therapeutics, Inc.
Accepted 2022-04-05 00:00:00 ET · period of report 2022-04-01 · accession 0001209191-22-023037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-05 | 2022-04-01 | KROS | Rovaldi Christopher | COO | S - Sale+OE | $57.49 | -864 | 0 | -100% | -$49.7K |
| D | 2022-04-05 | 2022-04-01 | KROS | Rovaldi Christopher | COO | M - OptEx | $16.00 | +864 | 864 | New | +$13.8K |
| D | 2022-04-05 | 2022-04-01 | KROS | Rovaldi Christopher | COO | M - OptEx | $0.00 | -864 | 9,730 | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-01 | S | D | 287 | $56.89 | 471 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.50 to $57.43 inclusive. |
| 2 | Common | Common Stock | 2022-04-01 | S | D | 104 | $56.20 | 758 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.50 to $56.23 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5). |
| 3 | Common | Common Stock | 2022-04-01 | S | D | 2 | $54.34 | 862 | D | — | — | |
| 4 | Common | Common Stock | 2022-04-01 | M | A | 864 | $16.00 | 864 | D | — | — | |
| 5 | Common | Common Stock | 2022-04-01 | S | D | 366 | $57.97 | 105 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.58 to $58.26 inclusive. |
| 6 | Common | Common Stock | 2022-04-01 | S | D | 105 | $58.83 | 0 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.62 to $59.275 inclusive. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2022-04-01 | M | D | 864 | $0.00 | 9,730 | D | $16.00 · — to 2030-04-07 | 864 Common Stock | (F6) One-fourth (1/4th) of the shares subject to the option vested on January 1, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |